Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Astellas Acquires Universal Cells for up to $102.5M

Thursday, February 15, 2018   (0 Comments)
Share |



Astellas Pharma (OTCPK:ALPMF) has acquired Seattle, WA-based Universal Cells, Inc. and its Universal Donor Cell technology enabling the creation of cell therapy products that do not require human leukocyte antigen (HLA) matching which greatly reduces the risk of rejection.

Under the terms of the deal, Astellas will pay up to $102.5M in upfront and milestone payments for 100% ownership of Universal Cells. Astellas says the transaction will not have a material impact on its financial results for fiscal 2018 (year-end March 31).

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal